Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,024.54
-7.1163-0.35%
Number of Gainers:4
Number of Losers:6
Number of Flat:1
PE:- -
High:2,052.89
Open:2,052.89
Low:2,016.27
Close:2,031.66
Volume:22.33M
Turnover:1.06B
Market Cap:224.10B
Float Cap:223.40B

Loading ...

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Quest Diagnostics Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

GeoVax Labs Announces Special Shareholder Meeting

Reuters
·
Sep 11

GeoVax Appeals NASDAQ Delisting Notice Tied to Minimum Bid Price Rule

Reuters
·
Sep 11

Apple Health app users can order labs from Quest Diagnostics

TIPRANKS
·
Sep 10

Quest Diagnostics Lab Testing to be Available for Purchase in Apple Health App Later This Year

Reuters
·
Sep 10

Viatris Price Target Announced at $20.00/Share by Leerink Partners

Dow Jones
·
Sep 09

U.S. Stocks on the MOVE-UGI, Chewy, Cognyte Software

Reuters
·
Sep 09

Leerink Starts Viatris at 'outperform' on Improving Growth

Reuters
·
Sep 09

Emergent Biosolutions Price Target Maintained with a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 09

Viatris Inc. : Leerink Partners Initiates Coverage with Outperform Rating; Price Target $20

THOMSON REUTERS
·
Sep 09

Viatris initiated with an Outperform at Leerink

TIPRANKS
·
Sep 09

Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead

Dow Jones
·
Sep 09

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Assembly Bio Highlights Phase 2 Starts for ABI-6250, GS-1179 in Pipeline Update

Reuters
·
Sep 09

Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program

THOMSON REUTERS
·
Sep 09

Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement

TradingKey
·
Sep 09

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines

THOMSON REUTERS
·
Sep 09

Quest Diagnostics Inc : UBS Raises Target Price to $245 from $232

THOMSON REUTERS
·
Sep 08